Table of Contents 1 Study Coverage 1.1 Sustained Release Injectables Product Introduction 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Sustained Release Injectables Market Size Growth Rate by Type 1.4.2 Naltrexone 1.4.3 Exenatide 1.4.4 Estradiol 1.4.5 Other 1.5 Market by Application 1.5.1 Global Sustained Release Injectables Market Size Growth Rate by Application 1.5.2 Diabetes 1.5.3 Leukemia 1.5.4 Acromegaly 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Sustained Release Injectables Market Size 2.1.1 Global Sustained Release Injectables Revenue 2014-2025 2.1.2 Global Sustained Release Injectables Sales 2014-2025 2.2 Sustained Release Injectables Growth Rate by Regions 2.2.1 Global Sustained Release Injectables Sales by Regions 2.2.2 Global Sustained Release Injectables Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Sustained Release Injectables Sales by Manufacturers 3.1.1 Sustained Release Injectables Sales by Manufacturers 3.1.2 Sustained Release Injectables Sales Market Share by Manufacturers 3.2 Sustained Release Injectables Revenue by Manufacturers 3.2.1 Sustained Release Injectables Revenue by Manufacturers (2014-2019) 3.2.2 Sustained Release Injectables Revenue Share by Manufacturers (2014-2019) 3.3 Sustained Release Injectables Price by Manufacturers 3.4 Sustained Release Injectables Manufacturing Base Distribution, Product Types 3.4.1 Sustained Release Injectables Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Sustained Release Injectables Product Type 3.4.3 Date of International Manufacturers Enter into Sustained Release Injectables Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Sustained Release Injectables Sales by Type 4.2 Global Sustained Release Injectables Revenue by Type 4.3 Sustained Release Injectables Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Sustained Release Injectables Breakdown Data by Application 6 North America 6.1 North America Sustained Release Injectables by Country 6.1.1 North America Sustained Release Injectables Sales by Country 6.1.2 North America Sustained Release Injectables Revenue by Country 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Sustained Release Injectables by Type 6.3 North America Sustained Release Injectables by Application 7 Europe 7.1 Europe Sustained Release Injectables by Country 7.1.1 Europe Sustained Release Injectables Sales by Country 7.1.2 Europe Sustained Release Injectables Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Sustained Release Injectables by Type 7.3 Europe Sustained Release Injectables by Application 8 Asia Pacific 8.1 Asia Pacific Sustained Release Injectables by Region 8.1.1 Asia Pacific Sustained Release Injectables Sales by Region 8.1.2 Asia Pacific Sustained Release Injectables Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Thailand 8.1.10 Malaysia 8.1.11 Philippines 8.1.12 Vietnam 8.2 Asia Pacific Sustained Release Injectables by Type 8.3 Asia Pacific Sustained Release Injectables by Application 9 Central & South America 9.1 Central & South America Sustained Release Injectables by Country 9.1.1 Central & South America Sustained Release Injectables Sales by Country 9.1.2 Central & South America Sustained Release Injectables Revenue by Country 9.1.3 Brazil 9.2 Central & South America Sustained Release Injectables by Type 9.3 Central & South America Sustained Release Injectables by Application 10 Middle East and Africa 10.1 Middle East and Africa Sustained Release Injectables by Country 10.1.1 Middle East and Africa Sustained Release Injectables Sales by Country 10.1.2 Middle East and Africa Sustained Release Injectables Revenue by Country 10.1.3 Turkey 10.1.4 GCC Countries 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Sustained Release Injectables by Type 10.3 Middle East and Africa Sustained Release Injectables by Application 11 Company Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Details 11.1.2 Company Business Overview 11.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.1.4 AstraZeneca Sustained Release Injectables Products Offered 11.1.5 AstraZeneca Recent Development 11.2 Eli Lilly 11.2.1 Eli Lilly Company Details 11.2.2 Company Business Overview 11.2.3 Eli Lilly Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Eli Lilly Sustained Release Injectables Products Offered 11.2.5 Eli Lilly Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Company Business Overview 11.3.3 Sanofi Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Sanofi Sustained Release Injectables Products Offered 11.3.5 Sanofi Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Company Business Overview 11.4.3 Roche Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Roche Sustained Release Injectables Products Offered 11.4.5 Roche Recent Development 11.5 Novartis 11.5.1 Novartis Company Details 11.5.2 Company Business Overview 11.5.3 Novartis Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Novartis Sustained Release Injectables Products Offered 11.5.5 Novartis Recent Development 11.6 Aurobindo 11.6.1 Aurobindo Company Details 11.6.2 Company Business Overview 11.6.3 Aurobindo Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Aurobindo Sustained Release Injectables Products Offered 11.6.5 Aurobindo Recent Development 11.7 Avadel 11.7.1 Avadel Company Details 11.7.2 Company Business Overview 11.7.3 Avadel Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Avadel Sustained Release Injectables Products Offered 11.7.5 Avadel Recent Development 11.8 Biomarin 11.8.1 Biomarin Company Details 11.8.2 Company Business Overview 11.8.3 Biomarin Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Biomarin Sustained Release Injectables Products Offered 11.8.5 Biomarin Recent Development 11.9 Camurus 11.9.1 Camurus Company Details 11.9.2 Company Business Overview 11.9.3 Camurus Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Camurus Sustained Release Injectables Products Offered 11.9.5 Camurus Recent Development 11.10 Critical Pharmaceuticals 11.10.1 Critical Pharmaceuticals Company Details 11.10.2 Company Business Overview 11.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Critical Pharmaceuticals Sustained Release Injectables Products Offered 11.10.5 Critical Pharmaceuticals Recent Development 11.11 Alkermes 11.12 Amylin 11.13 Ascendis Pharma 11.14 Taiwan Liposome Company 12 Future Forecast 12.1 Sustained Release Injectables Market Forecast by Regions 12.1.1 Global Sustained Release Injectables Sales Forecast by Regions 2019-2025 12.1.2 Global Sustained Release Injectables Revenue Forecast by Regions 2019-2025 12.2 Sustained Release Injectables Market Forecast by Type 12.2.1 Global Sustained Release Injectables Sales Forecast by Type 2019-2025 12.2.2 Global Sustained Release Injectables Revenue Forecast by Type 2019-2025 12.3 Sustained Release Injectables Market Forecast by Application 12.4 North America Sustained Release Injectables Forecast 12.5 Europe Sustained Release Injectables Forecast 12.6 Asia Pacific Sustained Release Injectables Forecast 12.7 Central & South America Sustained Release Injectables Forecast 12.8 Middle East and Africa Sustained Release Injectables Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Sustained Release Injectables Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Sustained Release Injectables Product Picture Table Sustained Release Injectables Market Segments Table Key Manufacturers Sustained Release Injectables Covered Table Global Sustained Release Injectables Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$) Figure Global Sustained Release Injectables Sales Market Share by Type in 2018 & 2025 Figure Naltrexone Product Picture Table Major Manufacturers of Naltrexone Figure Exenatide Product Picture Table Major Manufacturers of Exenatide Figure Estradiol Product Picture Table Major Manufacturers of Estradiol Figure Other Product Picture Table Major Manufacturers of Other Table Global Sustained Release Injectables Market Size Growth Rate by Application 2019-2025 (K Units) Figure Global Sustained Release Injectables 4900 Sales Market Share by Application in 2018 Figure Diabetes Figure Leukemia Figure Acromegaly Figure Other Figure Sustained Release Injectables Report Years Considered Figure Global Sustained Release Injectables Market Size 2014-2025 (Million US$) Figure Global Sustained Release Injectables Sales 2014-2025 (K Units) Table Global Sustained Release Injectables Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Sustained Release Injectables Sales by Regions 2014-2019 (K Units) Table Global Sustained Release Injectables Sales Market Share by Regions 2014-2019 Figure Global Sustained Release Injectables Sales Market Share by Regions 2014-2019 Figure 2018 Global Sustained Release Injectables Sales Market Share by Regions Table Global Sustained Release Injectables Revenue by Regions 2014-2019 (Million US$) Table Global Sustained Release Injectables Revenue Market Share by Regions 2014-2019 Figure Global Sustained Release Injectables Revenue Market Share by Regions 2014-2019 Figure 2018 Global Sustained Release Injectables Revenue Market Share by Regions Table Global Sustained Release Injectables Sales by Manufacturers (2014-2019) (K Units) Table Global Sustained Release Injectables Sales Share by Manufacturers (2014-2019) Figure Global Sustained Release Injectables Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Sustained Release Injectables Revenue by Manufacturers (2014-2019) (Million USD) Table Sustained Release Injectables Revenue Share by Manufacturers (2014-2019) Figure Sustained Release Injectables Value Share by Manufacturers in 2018 Table Key Manufacturers Sustained Release Injectables Price (2014-2019) (USD/Unit) Table Sustained Release Injectables Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Sustained Release Injectables Product Type Table Date of International Manufacturers Enter into Sustained Release Injectables Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Sustained Release Injectables Sales by Type (2014-2019) (K Units) Table Global Sustained Release Injectables Sales Share by Type (2014-2019) Figure Global Sustained Release Injectables Sales Market Share by Type (2014-2019) Figure Global Sustained Release Injectables Sales Market Share by Type in 2018 Table Global Sustained Release Injectables Revenue by Type (2014-2019) (Million US$) Table Global Sustained Release Injectables Revenue Share by Type (2014-2019) Figure Global Sustained Release Injectables Revenue Market Share by Type (2014-2019) Figure Global Sustained Release Injectables Revenue Market Share by Type in 2018 Table Sustained Release Injectables Price by Type 2014-2019 (USD/Unit) Table Global Sustained Release Injectables Sales by Application (2014-2019) (K Units) Table Global Sustained Release Injectables Sales Share by Application (2014-2019) Figure Global Sales Sustained Release Injectables Market Share by Application (2014-2019) Figure Global Sales Sustained Release Injectables Market Share by Application in 2018 Figure North America Sustained Release Injectables Sales Growth Rate 2014-2019 (K Units) Figure North America Sustained Release Injectables Revenue Growth Rate 2014-2019 (Million US$) Table North America Sustained Release Injectables Sales by Country (2014-2019) (K Units) Table North America Sustained Release Injectables Sales Market Share by Country (2014-2019) Figure 2018 North America Sustained Release Injectables Sales Market Share by Country Table North America Sustained Release Injectables Revenue by Country (2014-2019) (Million US$) Table North America Sustained Release Injectables Revenue Market Share by Country (2014-2019) Figure 2018 North America Sustained Release Injectables Revenue Market Share by Country Figure United States Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure United States Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Canada Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Canada Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Mexico Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Table North America Sustained Release Injectables Sales by Type (2014-2019) (K Units) Table North America Sustained Release Injectables Sales Market Share by Type (2014-2019) Figure 2018 North America Sustained Release Injectables Market Share by Type Table North America Sustained Release Injectables Sales by Application (2014-2019) (K Units) Table North America Sustained Release Injectables Sales Market Share by Application (2014-2019) Figure 2018 North America Sustained Release Injectables Market Share by Application Figure Europe Sustained Release Injectables Sales Growth Rate 2014-2019 (K Units) Figure Europe Sustained Release Injectables Revenue Growth Rate 2014-2019 (Million US$) Table Europe Sustained Release Injectables Sales by Country (2014-2019) (K Units) Table Europe Sustained Release Injectables Sales Market Share by Country (2014-2019) Figure 2018 Europe Sustained Release Injectables Sales Market Share by Country Table Europe Sustained Release Injectables Revenue by Country (2014-2019) (Million US$) Table Europe Sustained Release Injectables Revenue Market Share by Country (2014-2019) Figure 2018 Europe Sustained Release Injectables Revenue Market Share by Country Figure Germany Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Germany Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure France Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure France Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure UK Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure UK Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Italy Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Russia Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Table Europe Sustained Release Injectables Sales by Type (2014-2019) (K Units) Table Europe Sustained Release Injectables Sales Market Share by Type (2014-2019) Figure 2018 Europe Sustained Release Injectables Market Share by Type Table Europe Sustained Release Injectables Sales by Application (2014-2019) (K Units) Table Europe Sustained Release Injectables Sales Market Share by Application (2014-2019) Figure 2018 Europe Sustained Release Injectables Market Share by Application Figure Asia Pacific Sustained Release Injectables Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Sustained Release Injectables Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Sustained Release Injectables Sales by Region (2014-2019) (K Units) Table Asia Pacific Sustained Release Injectables Sales Market Share by Region (2014-2019) Figure 2018 Asia Pacific Sustained Release Injectables Sales Market Share by Region Table Asia Pacific Sustained Release Injectables Revenue by Region (2014-2019) (Million US$) Table Asia Pacific Sustained Release Injectables Revenue Market Share by Region (2014-2019) Figure 2018 Asia Pacific Sustained Release Injectables Revenue Market Share by Country Figure China Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure China Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Japan Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure South Korea Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure South Korea Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure India Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure India Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Australia Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Thailand Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Philippines Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Sustained Release Injectables Sales by Type (2014-2019) (K Units) Table Asia Pacific Sustained Release Injectables Sales Market Share by Type (2014-2019) Figure 2018 Asia Pacific Sustained Release Injectables Market Share by Type Table Asia Pacific Sustained Release Injectables Sales by Application (2014-2019) (K Units) Table Asia Pacific Sustained Release Injectables Sales Market Share by Application (2014-2019) Figure 2018 Asia Pacific Sustained Release Injectables Market Share by Application Figure Central & South America Sustained Release Injectables Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Sustained Release Injectables Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Sustained Release Injectables Sales by Country (2014-2019) (K Units) Table Central & South America Sustained Release Injectables Sales Market Share by Country (2014-2019) Figure 2018 Central & South America Sustained Release Injectables Sales Market Share by Country Table Central & South America Sustained Release Injectables Revenue by Country (2014-2019) (Million US$) Table Central & South America Sustained Release Injectables Revenue Market Share by Country (2014-2019) Figure 2018 Central & South America Sustained Release Injectables Revenue Market Share by Country Figure Brazil Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Brazil Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Sustained Release Injectables Sales by Type (2014-2019) (K Units) Table Central & South America Sustained Release Injectables Sales Market Share by Type (2014-2019) Figure 2018 Central & South America Sustained Release Injectables Market Share by Type Table Central & South America Sustained Release Injectables Sales by Application (2014-2019) (K Units) Table Central & South America Sustained Release Injectables Sales Market Share by Application (2014-2019) Figure 2018 Central & South America Sustained Release Injectables Market Share by Application Figure Middle East and Africa Sustained Release Injectables Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Sustained Release Injectables Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Sustained Release Injectables Sales by Country (2014-2019) (K Units) Table Middle East and Africa Sustained Release Injectables Sales Market Share by Country (2014-2019) Figure 2018 Middle East and Africa Sustained Release Injectables Sales Market Share by Country Table Middle East and Africa Sustained Release Injectables Revenue by Country (2014-2019) (Million US$) Table Middle East and Africa Sustained Release Injectables Revenue Market Share by Country (2014-2019) Figure 2018 Middle East and Africa Sustained Release Injectables Revenue Market Share by Country Figure Turkey Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Turkey Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure GCC Countries Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure Egypt Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Sustained Release Injectables Sales Growth Rate (2014-2019) (K Units) Figure South Africa Sustained Release Injectables Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Sustained Release Injectables Sales by Type (2014-2019) (K Units) Table Middle East and Africa Sustained Release Injectables Sales Market Share by Type (2014-2019) Figure 2018 Middle East and Africa Sustained Release Injectables Market Share by Type Table Middle East and Africa Sustained Release Injectables Sales by Application (2014-2019) (K Units) Table Middle East and Africa Sustained Release Injectables Sales Market Share by Application (2014-2019) Figure 2018 Middle East and Africa Sustained Release Injectables Market Share by Application Table AstraZeneca Company Details Table AstraZeneca Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca Recent Development Table Eli Lilly Company Details Table Eli Lilly Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Eli Lilly Recent Development Table Sanofi Company Details Table Sanofi Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi Recent Development Table Roche Company Details Table Roche Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Recent Development Table Novartis Company Details Table Novartis Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Recent Development Table Aurobindo Company Details Table Aurobindo Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Aurobindo Recent Development Table Avadel Company Details Table Avadel Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Avadel Recent Development Table Biomarin Company Details Table Biomarin Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Biomarin Recent Development Table Camurus Company Details Table Camurus Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Camurus Recent Development Table Critical Pharmaceuticals Company Details Table Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Critical Pharmaceuticals Recent Development Table Alkermes Company Details Table Amylin Company Details Table Ascendis Pharma Company Details Table Taiwan Liposome Company Company Details Table Global Sustained Release Injectables Sales Forecast by Regions 2019-2025 (K Units) Table Global Sustained Release Injectables Sales Market Share Forecast by Regions 2019-2025 Table Global Sustained Release Injectables Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Sustained Release Injectables Revenue Market Share Forecast by Regions 2019-2025 Table Global Sustained Release Injectables Sales Forecast by Type 2019-2025 (K Units) Table Global Sustained Release Injectables Sales Market Share Forecast by Type 2019-2025 Table Global Sustained Release Injectables Revenue Forecast by Type 2019-2025 (Million US$) Table Global Sustained Release Injectables Revenue Market Share Forecast by Type 2019-2025 Table Global Sustained Release Injectables Sales Forecast by Application 2019-2025 (K Units) Table Global Sustained Release Injectables Sales Market Share Forecast by Application 2019-2025 Figure North America Sustained Release Injectables Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Sustained Release Injectables Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Sustained Release Injectables Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Sustained Release Injectables Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Sustained Release Injectables Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Sustained Release Injectables Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Sustained Release Injectables Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Sustained Release Injectables Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Sustained Release Injectables Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Sustained Release Injectables Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Key Opportunities and Drivers: Impact Analysis (2019-2025) Table Key Challenges Table Market Risks Figure Porter's Five Forces Analysis Table Sustained Release Injectables Value Chain Table Sustained Release Injectables Customers List Figure Channels of Distribution Table Sustained Release Injectables Distributors List Figure Distributors Profiles Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Figure Key Executives Interviewed Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AstraZeneca Eli Lilly Sanofi Roche Novartis Aurobindo Avadel Biomarin Camurus Critical Pharmaceuticals Alkermes Amylin Ascendis Pharma Taiwan Liposome Company